On March 16, 2026, Abeona Therapeutics Inc. announced the adoption of its Third Amended and Restated Bylaws, which will take effect immediately. The new bylaws replace the previous version dated July 9, 2024, and introduce several clarifying changes regarding the conduct of stockholder meetings. Key amendments include provisions for virtual meetings, adjustments to the quorum requirements, and enhanced procedural mechanics for stockholder proposals and nominations. These changes aim to align the company's governance practices with current regulatory standards and improve operational efficiency. The adoption of these bylaws is considered an administrative update and is not expected to have a significant impact on the company's stock price.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.